Replies to post #611072 on NorthWest Biotherapeutics Inc (NWBO)

[Rh2022]

Along with:

Reading between the lines, small to mid-size cell and gene therapy biotechs complained to the FDA about the amount of paperwork they have had to submit to get approval and the FDA is cleaning it up. $NWBO https://t.co/2qmtu4gblL

— Bio99 (@BIO99_BIO99) July 7, 2023

[flipper44]

From all appearances it looks like they had 27 modules pre-assessed by MHRA in 1/3 the possible time. If true, I’m impressed, and I haven't been impressed by much in the way of NWBO and/or regulator speed over the last decade.